{"id":"https://openalex.org/W2921998404","doi":"https://doi.org/10.1097/rli.0000000000000556","title":"Assessment of Pharmacokinetic, Pharmacodynamic Profile, and Tolerance of Gadopiclenol, A New High Relaxivity GBCA, in Healthy Subjects and Patients With Brain Lesions (Phase I/IIa Study)","display_name":"Assessment of Pharmacokinetic, Pharmacodynamic Profile, and Tolerance of Gadopiclenol, A New High Relaxivity GBCA, in Healthy Subjects and Patients With Brain Lesions (Phase I/IIa Study)","publication_year":2019,"publication_date":"2019-03-13","ids":{"openalex":"https://openalex.org/W2921998404","doi":"https://doi.org/10.1097/rli.0000000000000556","mag":"2921998404","pmid":"https://pubmed.ncbi.nlm.nih.gov/30870257"},"language":"en","primary_location":{"id":"doi:10.1097/rli.0000000000000556","doi":"https://doi.org/10.1097/rli.0000000000000556","is_oa":true,"landing_page_url":"https://doi.org/10.1097/rli.0000000000000556","pdf_url":null,"source":{"id":"https://openalex.org/S136338150","display_name":"Investigative Radiology","issn_l":"0020-9996","issn":["0020-9996","1536-0210"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative Radiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/rli.0000000000000556","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102901762","display_name":"Jing Hao","orcid":"https://orcid.org/0000-0002-5504-1948","observed_orcids":["https://orcid.org/0000-0002-5504-1948"]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jing Hao","raw_affiliation_strings":["From the Guerbet, Roissy CDG Cedex, France","Conflicts of interest and sources of funding: J.H., P.B., and P.D. are employees of Guerbet. This work is part of the ISEULT project and was funded in part by Banque Publique d'Investissement (France) and by Guerbet","Jing Hao, MD, Guerbet, BP57400, 95943 Roissy CDG Cedex, France. E-mail: [email\u00a0protected]","the Guerbet, Roissy CDG Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Guerbet, Roissy CDG Cedex, France","institution_ids":["https://openalex.org/I120615911"]},{"raw_affiliation_string":"Conflicts of interest and sources of funding: J.H., P.B., and P.D. are employees of Guerbet. This work is part of the ISEULT project and was funded in part by Banque Publique d'Investissement (France) and by Guerbet","institution_ids":["https://openalex.org/I120615911"]},{"raw_affiliation_string":"Jing Hao, MD, Guerbet, BP57400, 95943 Roissy CDG Cedex, France. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I120615911"]},{"raw_affiliation_string":"the Guerbet, Roissy CDG Cedex, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110298834","display_name":"Philippe Bourrinet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Bourrinet","raw_affiliation_strings":["Conflicts of interest and sources of funding: J.H., P.B., and P.D. are employees of Guerbet. This work is part of the ISEULT project and was funded in part by Banque Publique d'Investissement (France) and by Guerbet","the Guerbet, Roissy CDG Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: J.H., P.B., and P.D. are employees of Guerbet. This work is part of the ISEULT project and was funded in part by Banque Publique d'Investissement (France) and by Guerbet","institution_ids":["https://openalex.org/I120615911"]},{"raw_affiliation_string":"the Guerbet, Roissy CDG Cedex, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012391695","display_name":"Pierre Desch\u00e9","orcid":"https://orcid.org/0000-0002-2389-0697","observed_orcids":["https://orcid.org/0000-0002-2389-0697"]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Desch\u00e9","raw_affiliation_strings":["Conflicts of interest and sources of funding: J.H., P.B., and P.D. are employees of Guerbet. This work is part of the ISEULT project and was funded in part by Banque Publique d'Investissement (France) and by Guerbet","the Guerbet, Roissy CDG Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest and sources of funding: J.H., P.B., and P.D. are employees of Guerbet. This work is part of the ISEULT project and was funded in part by Banque Publique d'Investissement (France) and by Guerbet","institution_ids":["https://openalex.org/I120615911"]},{"raw_affiliation_string":"the Guerbet, Roissy CDG Cedex, France","institution_ids":["https://openalex.org/I120615911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102901762"],"corresponding_institution_ids":["https://openalex.org/I120615911"],"apc_list":null,"apc_paid":null,"fwci":1.6981,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.83236619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"54","issue":"7","first_page":"396","last_page":"402"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11279","display_name":"Lanthanide and Transition Metal Complexes","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11279","display_name":"Lanthanide and Transition Metal Complexes","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10378","display_name":"Advanced MRI Techniques and Applications","score":0.09080000221729279,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gadopiclenol","display_name":"gadopiclenol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.968999981880188},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9850000143051147},{"id":"https://openalex.org/keywords/brain-lesions","display_name":"brain lesions","score":0.6420000195503235},{"id":"https://openalex.org/keywords/mri-contrast-enhancement","display_name":"MRI contrast enhancement","score":0.6909999847412109},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.5929999947547913},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3619999885559082},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6050000190734863},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.6800000071525574},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6100000143051147},{"id":"https://openalex.org/keywords/signal-to-noise-ratio","display_name":"signal-to-noise ratio","score":0.7670000195503235},{"id":"https://openalex.org/keywords/contrast-to-noise-ratio","display_name":"contrast-to-noise ratio","score":0.9610000252723694},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5910000205039978},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.4909999966621399},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.4620000123977661},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6639999747276306},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.5509999990463257},{"id":"https://openalex.org/keywords/genotoxicity","display_name":"genotoxicity","score":0.40400001406669617},{"id":"https://openalex.org/keywords/immunotoxicity","display_name":"immunotoxicity","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.9026774168014526},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8170527219772339},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7478982210159302},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.690525233745575},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.5177023410797119},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.5009541511535645},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.4970286190509796},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43314674496650696},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.4285370111465454},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4124767780303955},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3260580897331238},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2781798243522644},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2369641363620758},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2263825535774231},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.19094184041023254},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005682","descriptor_name":"Gadolinium","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005682","descriptor_name":"Gadolinium","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/rli.0000000000000556","doi":"https://doi.org/10.1097/rli.0000000000000556","is_oa":true,"landing_page_url":"https://doi.org/10.1097/rli.0000000000000556","pdf_url":null,"source":{"id":"https://openalex.org/S136338150","display_name":"Investigative Radiology","issn_l":"0020-9996","issn":["0020-9996","1536-0210"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative Radiology","raw_type":"journal-article"},{"id":"pmid:30870257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30870257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative radiology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1097/rli.0000000000000556","doi":"https://doi.org/10.1097/rli.0000000000000556","is_oa":true,"landing_page_url":"https://doi.org/10.1097/rli.0000000000000556","pdf_url":null,"source":{"id":"https://openalex.org/S136338150","display_name":"Investigative Radiology","issn_l":"0020-9996","issn":["0020-9996","1536-0210"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative Radiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1804136389","https://openalex.org/W1827699998","https://openalex.org/W1970793787","https://openalex.org/W1988822345","https://openalex.org/W1991739011","https://openalex.org/W1993470842","https://openalex.org/W2012261363","https://openalex.org/W2030003406","https://openalex.org/W2043087048","https://openalex.org/W2058875663","https://openalex.org/W2058914126","https://openalex.org/W2059283030","https://openalex.org/W2061612871","https://openalex.org/W2061948232","https://openalex.org/W2071712292","https://openalex.org/W2084893557","https://openalex.org/W2119489822","https://openalex.org/W2125409822","https://openalex.org/W2136421454","https://openalex.org/W2140036864","https://openalex.org/W2150489367","https://openalex.org/W2169262628","https://openalex.org/W2318259483","https://openalex.org/W2322781671","https://openalex.org/W2343520020","https://openalex.org/W2353345075","https://openalex.org/W2409203058","https://openalex.org/W2792058008","https://openalex.org/W2888734247"],"related_works":["https://openalex.org/W6908425366","https://openalex.org/W4388302622","https://openalex.org/W2999830370","https://openalex.org/W4387439830","https://openalex.org/W2931677153","https://openalex.org/W4220652826","https://openalex.org/W4412727332","https://openalex.org/W4411186244","https://openalex.org/W2982408692","https://openalex.org/W4404582623"],"abstract_inverted_index":{"OBJECTIVES:":[0],"The":[1,323],"aim":[2],"of":[3,15,143,146,199,235,253,270,325,371],"this":[4],"study":[5,381],"was":[6,37,47,83,132,166,217,241,310,316],"to":[7,169,179,213,237],"evaluate":[8],"the":[9,144,197,224,245,255,368,387],"pharmacokinetics,":[10],"safety":[11,164,308,339],"profile,":[12],"and":[13,28,51,65,72,85,99,111,117,149,162,177,249,279,292,307,312,332],"pharmacodynamics":[14],"gadopiclenol,":[16,254],"a":[17,38,113,140,230,304,362],"new":[18],"high":[19],"relaxivity":[20],"macrocyclic":[21,349,364],"gadolinium-based":[22,350],"contrast":[23,256,314,351,365],"agent,":[24],"in":[25,78,105,118,219,244,259,264,286,329,342,356],"healthy":[26,54,189,330],"subjects":[27,69,190,331],"patients":[29,88,297,333,357],"with":[30,89,204,229,276,334,344,367],"brain":[31,90,147,260,335],"lesions.":[32,336],"MATERIALS":[33],"AND":[34],"METHODS:":[35],"This":[36],"single":[39],"ascending":[40],"dose":[41,58,94,266,373],"phase":[42,175,185],"I/IIa":[43],"study.":[44],"Phase":[45,81],"I":[46,176],"double-blind,":[48],"randomized,":[49],"placebo-controlled":[50],"included":[52,86,139],"54":[53],"subjects.":[55],"In":[56,188],"each":[57],"group":[59,95],"(0.025,":[60],"0.05,":[61],"0.075,":[62,97],"0.1,":[63,98],"0.2,":[64],"0.3":[66],"mmol/kg),":[67],"6":[68],"received":[70,74],"gadopiclenol":[71,200,277,326,360],"3":[73,92],"placebo":[75,280],"(NaCl":[76],"0.9%)":[77],"intravenous":[79],"injection.":[80],"IIa":[82],"open-label":[84],"12":[87],"lesions,":[91],"per":[93],"(0.05,":[96],"0.2":[100],"mmol/kg).":[101],"Concentrations":[102],"were":[103,262,274,295],"measured":[104],"plasma":[106,228],"samples":[107],"collected":[108,123],"before":[109],"administration":[110,173,183,252],"over":[112],"24-hour":[114],"period":[115],"postadministration":[116],"urine":[119],"specimens":[120],"(phase":[121],"I)":[122],"until":[124],"7":[125,170],"days":[126,171],"after":[127,172,182],"administration.":[128],"A":[129,160],"noncompartmental":[130],"approach":[131],"used":[133],"for":[134,174,184,347,374],"pharmacokinetic":[135,306],"analysis.":[136],"Pharmacodynamic":[137],"assessments":[138],"qualitative":[141],"evaluation":[142],"visualization":[145],"structures/lesions":[148],"quantitative":[150],"measurements":[151],"(signal-to-noise":[152],"ratio,":[153],"contrast-to-noise":[154],"ratio)":[155],"on":[156,384],"magnetic":[157,377],"resonance":[158,378],"imaging.":[159],"clinical":[161,375],"biological":[163],"follow-up":[165],"performed":[167],"up":[168,178],"1":[180],"day":[181],"IIa.":[186],"RESULTS:":[187],"(male,":[191,298],"50%;":[192],"median":[193,300],"age,":[194,301],"26.0":[195],"years),":[196,303],"pharmacokinetics":[198,246,324],"is":[201,327,341,361,382],"considered":[202],"linear":[203],"mean":[205],"maximum":[206],"concentration":[207],"Cmax":[208],"values":[209],"ranging":[210],"from":[211,227],"248.7":[212],"3916.4":[214],"\u03bcg/mL.":[215],"Gadopiclenol":[216],"excreted":[218],"an":[220],"unchanged":[221],"form":[222],"via":[223],"kidneys,":[225],"eliminated":[226],"terminal":[231],"elimination":[232],"half-life":[233],"(t1/2)":[234],"1.5":[236],"2":[238],"hours.":[239],"There":[240],"no":[242],"difference":[243],"between":[247],"males":[248],"females.":[250],"After":[251],"enhancement":[257,315],"scores":[258],"structures":[261],"improved":[263],"all":[265,319],"groups.":[267],"Similar":[268],"rates":[269],"related":[271],"adverse":[272],"events":[273],"observed":[275],"(36.1%)":[278],"(33.3%).":[281],"No":[282],"clinically":[283],"significant":[284],"modifications":[285],"biochemistry,":[287],"hematology,":[288],"urinalysis,":[289],"electrocardiogram":[290],"parameters,":[291],"vital":[293],"signs":[294],"reported.In":[296],"58%;":[299],"53.0":[302],"similar":[305],"profile":[309,340],"observed,":[311],"sufficient":[313],"seen":[317],"at":[318],"tested":[320],"doses.":[321],"CONCLUSIONS:":[322],"dose-independent":[328],"Its":[337],"good":[338],"line":[343],"that":[345,359],"reported":[346],"other":[348],"agents.":[352],"Preliminary":[353],"pharmacodynamic":[354],"results":[355],"suggest":[358],"promising":[363],"agent":[366],"potential":[369],"use":[370],"lower":[372],"routine":[376],"imaging":[379],"scans.The":[380],"registered":[383],"ClinicalTrials.gov":[385],"under":[386],"trial":[388],"registration":[389],"number":[390],"NCT03603106.":[391]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-03-22T00:00:00"}